Home

Wei (William) Cao

CIK 1569980 · Chief Executive Officer · last filed 2016-04-14

Wei (William) Cao is a Chief Executive Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing, for CBMG, was dated Apr 14, 2016. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. 11 SEC filings were submitted jointly with EastBridge Investment Group Corp.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

9

Lifetime Open-Market Net

-$1.87M

Filer Profile

Reported Address
530 UNIVERSITY AVENUE, #17
PALO ALTO, CA 94301
Related Filers
EastBridge Investment Group Corp — 11 joint filings, latest 2016-04-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cellular Biomedicine Group, Inc. (CBMG) Delisted Chief Executive Officer 209,617 — — -$1.87M 8 2016-04-14

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-04-14 Cellular Biomedicine Group, Inc. (CBMG) Delisted Mixed — -$117.5K EDGAR
2016-03-04 Cellular Biomedicine Group, Inc. (CBMG) Delisted Mixed — -$91.1K EDGAR
2016-03-02 Cellular Biomedicine Group, Inc. (CBMG) Delisted Mixed — -$30.4K EDGAR
2015-11-30 Cellular Biomedicine Group, Inc. (CBMG) Delisted Sell (S) −48,046 -$1.13M EDGAR
2015-10-26 Cellular Biomedicine Group, Inc. (CBMG) Delisted Mixed — -$283.9K EDGAR
2015-02-17 Cellular Biomedicine Group, Inc. (CBMG) Delisted Grant (A) — $0 EDGAR
2014-10-31 Cellular Biomedicine Group, Inc. (CBMG) Delisted Other (J) +1,602 $0 EDGAR
2014-10-08 Cellular Biomedicine Group, Inc. (CBMG) Delisted Other (J) +23,543 $0 EDGAR
2013-02-22 — Grant (A) — $0
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.